We are live on ! Find out more
S

SignatureFD Portfolio holdings

AUM $7.49B
1-Year Est. Return 24.82%
This Fund
S&P 500
This Quarter Est. Return
-5.22%
1 Year Est. Return
+24.82%
3 Year Est. Return
+73.56%
5 Year Est. Return
+79.97%
10 Year Est. Return
+256.52%
AUM
$2.92B
AUM Growth
-$16.5M
Cap. Flow
+$148M
Cap. Flow %
5.06%
Top 10 Hldgs %
58.49%
Holding
3,484
New
270
Increased
1,486
Reduced
1,042
Closed
205

Sector Composition

Rank Sector Weight
1 Technology 6.43%
2 Financials 3.81%
3 Consumer Discretionary 3.81%
4 Healthcare 3.61%
5 Consumer Staples 2.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SM icon
2001
SM Energy
SM
$7.8B
$12K ﹤0.01%
327
+58
+22% +$2.28K
TLS icon
2002
Telos
TLS
$332M
$12K ﹤0.01%
1,334
-75
-5% -$691
UPLD icon
2003
Upland Software
UPLD
$12.8M
$12K ﹤0.01%
143
+109
+321% +$12.1K
VECO icon
2004
Veeco
VECO
$3.05B
$12K ﹤0.01%
636
+487
+327% +$9.96K
VTEB icon
2005
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
$12K ﹤0.01%
243
-8,208
-97% -$410K
WMS icon
2006
Advanced Drainage Systems
WMS
$10.6B
$12K ﹤0.01%
100
-85
-46% -$10.6K
TBRG
2007
DELISTED
TruBridge
TBRG
$12K ﹤0.01%
430
+14
+3% +$432
INVX
2008
Innovex International
INVX
$1.96B
$12K ﹤0.01%
623
+34
+6% +$788
BCPC
2009
Balchem Corp
BCPC
$5.38B
$12K ﹤0.01%
99
+42
+74% +$5.47K
TELL
2010
DELISTED
Tellurian Inc.
TELL
$12K ﹤0.01%
5,091
+1,810
+55% +$6.53K
AAN
2011
DELISTED
The Aaron's Company Inc
AAN
$12K ﹤0.01%
1,246
+10
+0.8% +$133
EGRX
2012
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$12K ﹤0.01%
466
-225
-33% -$8.26K
KNTE
2013
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$12K ﹤0.01%
965
+157
+19% +$2.06K
BFTR
2014
DELISTED
BlackRock Future Innovators ETF
BFTR
$12K ﹤0.01%
500
FOCS
2015
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$12K ﹤0.01%
382
+253
+196% +$9.65K
BRG
2016
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$12K ﹤0.01%
458
-86
-16% -$2.27K
HSKA
2017
DELISTED
Heska Corp
HSKA
$12K ﹤0.01%
162
+130
+406% +$11.5K
ACHC icon
2018
Acadia Healthcare
ACHC
$2.76B
$11K ﹤0.01%
143
+26
+22% +$2.08K
AFRM icon
2019
Affirm
AFRM
$23.9B
$11K ﹤0.01%
570
+84
+17% +$2.2K
ALGT icon
2020
Allegiant Air
ALGT
$2.64B
$11K ﹤0.01%
157
+153
+3,825% +$15.8K
BMBL icon
2021
Bumble
BMBL
$372M
$11K ﹤0.01%
524
-145
-22% -$4.29K
CBZ icon
2022
CBIZ
CBZ
$2.99B
$11K ﹤0.01%
251
-17
-6% -$744
CLB icon
2023
Core Laboratories
CLB
$490M
$11K ﹤0.01%
784
+161
+26% +$2.71K
CORT icon
2024
Corcept Therapeutics
CORT
$12.4B
$11K ﹤0.01%
444
CSW
2025
CSW Industrials
CSW
$5.2B
$11K ﹤0.01%
92
+40
+77% +$4.89K

Similar funds

SignatureFD's Q3 2022 Portfolio in Review

As of Q3 2022, SignatureFD held 3,484 positions worth $2.92B, down 0.56% from $2.94B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

SignatureFD deployed $148M of net new capital in Q3 2022, opening 270 new positions and adding to 1,486 existing holdings. Its largest new stake was Haleon: 85,323 shares worth $520K.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 6.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares MSCI USA Value Factor ETF, an estimated $174M trimmed.

  • SignatureFD's largest Q3 2022 buy was Haleon: 85,323 shares worth $520K.
  • SignatureFD added most to Vanguard FTSE Emerging Markets ETF in Q3 2022, an estimated $196M increase.
  • SignatureFD's biggest Q3 2022 reduction was iShares MSCI USA Value Factor ETF, cutting an estimated $174M.
  • SignatureFD fully exited Global X NASDAQ-100 Covered Call ETF in Q3 2022, selling an estimated $429K.
  • SignatureFD's ten largest holdings make up 58% of its $2.92B portfolio in Q3 2022.
  • SignatureFD opened 270 new positions and closed 205 in Q3 2022.
  • SignatureFD's portfolio value fell 0.56% quarter-over-quarter to $2.92B.

Based on SignatureFD's 13F filing for Q3 2022, filed 8 Nov 2022.